awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33759610-812A766E-E69B-448D-BCA8-6AA965A64CA8
Q33759610-812A766E-E69B-448D-BCA8-6AA965A64CA8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33759610-812A766E-E69B-448D-BCA8-6AA965A64CA8
Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.
P2860
Q33759610-812A766E-E69B-448D-BCA8-6AA965A64CA8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33759610-812A766E-E69B-448D-BCA8-6AA965A64CA8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1ae32eee0d75d527f0694b767484c3cf82677bbd
P2860
SGLT2 inhibitors: molecular design and potential differences in effect.